Item 7.01 Regulation FD Disclosure.

Press Release

On July 13, 2021, Recursion Pharmaceuticals, Inc. issued a press release announcing the formation of a Therapeutics Advisory Board, chaired by Joseph Miletich, MD, PhD. A copy of the press release is attached hereto as Exhibit 99.1.

The information furnished pursuant to Item 7.01 on this Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits



Exhibit No.       Description

99.1                Press Release, dated July 13, 2021.

104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses